BROSSARD, QUEBEC--(Marketwired - July 16, 2014) - Diagnos Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today the signing of a contract with Al Manama Medical Center for the deployment of a screening unit and usage of CARA in the Unite Arab Emirates, a project fully supported by the UAE Ministry of Health.
"DIAGNOS has been carrying out successful screening projects in the UAE since 2011, and, as a result, our business in the region is continuing to steadily grow. With the strong support of the UAE Ministry of Health, we remain optimistic that our business growth in the country will continue its upward trend. The UAE has grown to be an excellent reference for potential clients around the world," said Peter Nowacki, Diagnos' Vice-President.
About Al Manama Healthcare
Al Manama Healthcare is the primary healthcare center serving an area to the East of the Ajman Emirate, one of the seven emirates constituting the UAE. They currently serve approximately 1000 registered diabetic patients in the area and are planning an outreach program to cover a larger proportion of the area's population.
About DIAGNOS Healthcare
DIAGNOS Healthcare is a business division within DIAGNOS Inc., achieving international recognition as leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing. Through its Healthcare division, DIAGNOS offers turn-key diabetic retinopathy screening services to patients in various locations around the world.
For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com.